Seeking Alpha

Hansen Medical +21% as FDA clears Magellan 6Fr Robotic Catheter

  • Hansen Medical (HNSN +20.9%) says it received FDA clearance for its smaller diameter Magellan 6Fr Robotic Catheter for peripheral vascular interventions.
  • Also, HNSN announces the departure of CEO Bruce Barclay; current board member Chris Lowe is appointed interim CEO.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: